We received back the results of Tom's Prostate Biopsy and they did identify cancer in 3/15 core samples taken. The doctors ...

In recent years, small volume biopsies have been increasingly utilized for diagnosis of tumors in both primary and recurrent settings. Concomitantly, the numbers of ancillary studies for ...

This study recruited 65 women of whom 94% were node-positive, and 60% were hormone receptor-negative. The pCR rate was 41.5% and 53.8% for the whole cohort and the hormone receptor–negative subgroup, ...

Comprehensive Sequencing and Analysis of Circulating, Cell-Free DNA in Longitudinal Studies With the advent of liquid biopsy assays, it is now possible to monitor the treatment response of oncology ...

Why did you apply this technology to prostate cancer in particular? Dr. Dogra: As an adjunct professor of urology, I am interested in prostate cancer. It is the second leading cause of cancer death in ...

Two major eastern Idaho hospitals are taking a groundbreaking step to improve cancer care through a new technology that ...

DURHAM, N.C.--(BUSINESS WIRE)--GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced the launch of its EXpressCT SM (Expression ...